Virta Health Raises $93M to Combat the $400B Type 2 Diabetes Epidemic and Expand Diabetes Reversal to Millions SAN FRANCISCO, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Virta Health, the first company with a treatment to sustainably reverse type 2 diabetes (T2D) without medications or surgery, today announced that it...

Virta Health Engages with Willis Towers Watson to Accelerate Adoption of Type 2 Diabetes Reversal Treatment SAN FRANCISCO, June 18, 2019 (GLOBE NEWSWIRE) -- Virta Health, the first company to sustainably reverse type 2 diabetes without the use of medications or surgery, announced today a new engagement...

Virta Health Continues Rapid Growth with New Executives, New Customers, and Industry Validation for the Virta Treatment SAN FRANCISCO, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Virta Health, the first company with a clinically-proven treatment to safely and sustainably reverse type 2 diabetes (T2D) without the use...

Virta Health's Treatment for Sustained Type 2 Diabetes Reversal Provides New Hope for Chronic Disease Patients San Francisco, CA, Feb. 07, 2018 (GLOBE NEWSWIRE) --  Virta Health, the first company with a clinically-proven treatment to safely and sustainably reverse type 2 diabetes and other chronic metabolic...